Publication
Article
BioPharm International
BioPharm International-06-01-2002Volume15 Issue 6
Inside Washington: Safety, Risk, and Biotechnology Regulation
Author(s):
by Jill Wechsler Concerns about product safety and stiffer FDA regulation of manufacturers may be drying up the biotech pipeline
Articles in this issue
Negotiating and Structuring Strategic Alliances
Finding Funding in Biotechnology: Keeping the Companies Alive
Biotechnology Patent Holders Beware! A Supreme Court Ruling may Significantly Reduce the Value of Your Patent Portfolio
Guest Editorial: Enabling Collaboration in the Pharmaceutical Industry
Stem Cells and Xenotransplantation: Ethics, Patents, and Politics
Unlocking the Value of R&D: Managing the Risks
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Videos
Related Content
